Two independent groups working with advanced-stage cases say the drug extended the period before the disease worsened by more than 3.5 months.Avastin can stabilize tumors in women suffering from advanced-stage ovarian cancer, extending the period before the disease worsens by more than 3.5 months, according to the results of two large, international clinical trials conducted by separate research teams.
No comments:
Post a Comment